Earnings Releases

Silvaco Group, Inc. reported fourth quarter ended December 31, 2025 results: revenue $18.3 million, net income $7.2 million, EPS $0.24.

“Revenue of $18.3 million, up 2% year-over-year. . ◦ TCAD revenue of $8.8 million, down 31% year-over-year. ◦ EDA revenue of $4.4 million, up 4% year-over-year. ◦ SIP revenue of $5.1 million, up 483% year-over-year. • GAAP gross margin of 83%, down 310 basis points year-over-year. • GAAP operating loss of $6.8 million, compared to $2.4 million operating income in Q4 2024. • GAAP net loss of $7.2 million, compared to $4.2 million net income in Q4 2024. • GAAP basic and diluted net loss per share of $0.24, compared to basic and diluted net income per share of $0.14 in Q4 2024.”

Rubrik, Inc. reported Full fiscal year 2027 results: revenue Revenue of $1,597 million to $1,607 million., EPS Non-GAAP net income per share of $0.07 to $0.27.. Guidance initiated.

“Full Year 2027 Outlook: ▪ Subscription ARR between $1,829 million and $1,839 million. ▪ Revenue of $1,597 million to $1,607 million. ▪ Non-GAAP subscription ARR contribution margin of approximately 13%. ▪ Non-GAAP net income per share of $0.07 to $0.27. ▪ Weighted-average shares outstanding of approximately 232 million. ▪ Free cash flow of $265 million to $275 million.”

Rubrik, Inc. reported First quarter fiscal 2027 results: revenue Revenue of $365 million to $367 million., EPS Non-GAAP net loss per share of $(0.04) to $(0.02).. Guidance initiated.

“First Quarter Fiscal 2027 Outlook: ▪ Revenue of $365 million to $367 million. ▪ Non-GAAP subscription ARR contribution margin of 10% - 11%. ▪ Non-GAAP net loss per share of $(0.04) to $(0.02). ▪ Weighted-average shares outstanding of approximately 204 million.”

Rubrik, Inc. reported Fiscal year 2026 ended January 31, 2026 results: EPS GAAP net loss per share was $(1.78), compared to $(7.48) in fiscal 2025. GAAP net loss includes $329.4 million in stock-.

“Total revenue was $1.32 billion, a 48% increase, compared to $886.5 million in fiscal 2025.”

Rubrik, Inc. reported Fourth quarter fiscal 2026 ended January 31, 2026 results: EPS GAAP net loss per share was $(0.43), compared to $(0.61) in the fourth quarter of fiscal 2025. GAAP net loss includes $8.

“Total revenue was $377.7 million, a 46% increase compared to $258.1 million in the fourth quarter of fiscal 2025.”

MACH NATURAL RESOURCES LP reported the year ended December 31, 2025 results: revenue $1.2 billion, net income $143 million.

“For the full year 2025, Mach reported total revenue and net income of $1.2 billion and $143 million, respectively.”

MACH NATURAL RESOURCES LP reported the three months ended December 31, 2025 results: revenue $388 million, net income $73 million.

“Mach reported total revenue and net income of $388 million and $73 million in the fourth quarter of 2025, respectively.”

Sunrise Realty Trust, Inc. reported year ended December 31, 2025 results: net income $12.1 million, EPS $0.93 per basic weighted average common share.

“The Company reported GAAP net income of $12.1 million for the 2025 fiscal year, or $0.93 per basic weighted average common share”

Sunrise Realty Trust, Inc. reported fourth quarter ended December 31, 2025 results: net income $1.6 million, EPS $0.12 per basic weighted average common share.

“SUNS reported generally accepted accounting principles (“GAAP”) net income of $1.6 million for the fourth quarter of 2025, or $0.12 per basic weighted average common share”

TIC Solutions, Inc. updated its fiscal year 2026 guidance (initiated).

“Provides 2026 revenue and Adjusted EBITDA growth outlook”

TIC Solutions, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $508.3 million, net income Net Loss of $47.2 million.

“• 2025 Successor Revenue of $508.3 million compared to 2024 Successor Revenue of $262.0 million, representing an increase of 94%, primarily reflecting the inclusion of NV5 results. • 2025 Successor Net Loss of $47.2 million compared to 2024 Successor Net Loss of $15.6 million.”

TIC Solutions, Inc. reported the fiscal year ended December 31, 2025 results: revenue $1,530.3 million, net income Net Loss of $87.1 million.

“• 2025 Successor Revenue of $1,530.3 million compared to 2024 Predecessor Revenue of $633.9 million and 2024 Successor Revenue of $463.5 million, representing an increase of 39% based on prior-year Combined Revenue of $1.1 billion. • 2025 Successor Net Loss of $87.1 million compared to 2024 Predecessor Net Loss of $15.7 million and 2024 Successor Net Loss of $105.5 million, representing a 28% improvement based on prior-year Combined Net Loss of $121.2 million.”

Resolute Holdings Management, Inc. reported year ended December 31, 2025 results: EPS (0.69).

“For the year ended December 31, 2025, Resolute Holdings reported earnings per share attributable to common stockholders of ($0.69) and Non-GAAP Fee-Related Earnings per share of $0.11.”

Resolute Holdings Management, Inc. reported three months ended December 31, 2025 results: EPS (0.20).

“Resolute Holdings reported fourth quarter earnings per share attributable to common stockholders of ($0.20) and Non-GAAP Fee-Related Earnings per share of ($0.04).”

Jefferson Capital, Inc. / DE reported Full Year 2025 results: revenue $613.3 million.

“Strong revenue growth of 42% to $613.3 million”

Jefferson Capital, Inc. / DE reported Fourth Quarter 2025 results: revenue $154.8 million, net income $37.7 million, EPS $0.58.

“ibit 99.1 ​ Jefferson Capital Reports Fourth Quarter and Full Year 2025 Results ​ Record Quarterly Collections Grow 41% to $245.3 Million and Record Deployments Grow 6% to $380.5 Million Fourth Quarter Pre-tax Income up 50% to $44.1 Million with Net Income of $37.7 Million and EPS of $0.58 Fourth Quarter Adjusted Pre-tax Income up 15% to $51.1 Million with Adjusted Net Income of $44.7 Million and Adjusted EPS of $0.69 Board of Directors Declares Quarterly Cash Dividend of $0.24 per Share ​ MINNEAPOLIS, March 12, 2026 /GLOBE NEWSWIRE/ -- Jefferson Capital, Inc.”

Jefferson Capital, Inc. / DE reported the year ended December 31, 2025 results: revenue $613.3 million.

“EPS of $0.69 ​ Full Year 2025 Highlights (vs. Full Year 2024) ● Collections grew 71% to $998.7 million ● Deployments up 15% to $832.1 million ● Strong revenue growth of 42% to $613.3 million ● Sector-leading Cash Efficiency Ratio of 74.0% ● Net Operating Income up 44% to $316.5 million ● Pre-tax Income up 59% to $218.4 million ● Adjusted Pre-tax Income* up 44% to”

GrabAGun Digital Holdings Inc. reported the twelve months ended December 31, 2025 results: revenue $96.4 million, net income $2.5 million.

“• Net revenue was $96.4 million, up 3.6% year-over-year, compared to $93.1 million in FY 2024. o Firearms sales increased 9.7% to $81.2 million reflecting volume growth of 3.4%. o Non-firearms sales declined 20.1% to $15.2 million, reflecting 38.8% lower unit volume. • Gross profit margin of 11.7% compared with 10.4% gross profit margin in the prior year. • Loss from operations was $4.4 million compared to income from operations of $4.1 million in the prior year, driven by stock-based compensation expense and higher public company expenses following the Business Combination, including certain transaction-related expenses. • Net loss was $2.5 million compared to net income of $4.5 million in the prior year.”

GrabAGun Digital Holdings Inc. reported the three months ended December 31, 2025 results: revenue $29.6 million, net income $0.4 million.

“• Net revenue was $29.6 million, up 14.1% year-over-year, compared to $26.0 million in the prior-year quarter. o Firearms sales increased 19.1% to $25.7 million, reflecting volume growth of 11.5%. o Non-firearms sales declined 10.3% to $3.9 million, reflecting 34.7% lower unit volume. • Gross profit margin of 15.9% compared with 13.0% gross profit margin in the prior year quarter. • Loss from operations was $0.4 million compared to income from operations of $1.9 million in the prior year quarter, driven by stock-based compensation expense and public company expenses. • Net income was $0.4 million compared to net income of $2.0 million in the prior-year quarter.”

Sunbelt Rentals Holdings, Inc. updated its full-year fiscal 2026 guidance (raised).

“Narrowing and increasing midpoint of full-year fiscal 2026 outlook for rental revenue growth from 0% - 4% to 2% - 3%”

Sunbelt Rentals Holdings, Inc. reported fiscal year-to-date 2026 ended January 31, 2026 results: net income $1,099 million, EPS $2.60.

“Fiscal Year-to-date 2026 Highlights • Net income of $1,099 million and earnings per share of $2.60 • Adjusted earnings per share of $2.98 • Adjusted EBITDA of $3,610 million and adjusted EBITDA margin of 43.0% • Cash flow from operations of $2,834 million and free cash flow of $1,428 million • Total returns to shareholders of $1,354 million including $1,047 million of share buybacks and $307 million through dividends”

Sunbelt Rentals Holdings, Inc. reported fiscal third quarter of 2026 ended January 31, 2026 results: revenue $2,637 million, net income $290 million, EPS $0.69. Guidance raised.

“Fiscal Third Quarter 2026 Highlights • Total revenue of $2,637 million with rental revenue growth of 2.6% • Operating income of $492 million and operating income margin of 18.7% • Net income of $290 million and earnings per share of $0.69 • Adjusted earnings per share of $0.78 • Adjusted EBITDA of $1,082 million and adjusted EBITDA margin of 41.0%”

BK Technologies Corp updated its full year 2026 guidance (initiated).

“Introducing full year 2026 targets: $90 million in revenue, gross margin of +50%, GAAP EPS of over $3.15 per diluted share, and non-GAAP adjusted EPS 1 of $3.55 per diluted share.”

BK Technologies Corp reported fourth quarter and year ended December 31, 2025 results: revenue Revenue: 4Q25 revenue increased by 20% to $21.5 million; full year 2025 revenue grew 12.5% to $86.1 million., EPS 4Q25 Diluted EPS of $1.05; full year 2025 Diluted EPS of $3.44. Guidance initiated.

“BK Technologies Reports Fourth Quarter and Full Year 2025 Results Above Guidance ● Revenue: 4Q25 revenue increased by 20% to $21.5 million; full year 2025 revenue grew 12.5% to $86.1 million. ● Gross margins: 4Q25 gross margin expanded to 50.4% from 41.2% in 4Q24; full year 2025 gross margin increased to 48.8% from 37.9% in 2024. ● Earnings: 4Q25 Diluted EPS of $1.05, compared to $0.93 in 4Q24; full year 2025 Diluted EPS of $3.44, up from $2.25 in 2024.”

DOLLAR GENERAL CORP reported fourth quarter (13 weeks) and fiscal year (52 weeks) ended January 30, 2026 results: revenue $10.9 billion, net income $426.3 million, EPS $1.93.

“Dollar General Corporation (NYSE: DG) today reported financial results for its fourth quarter (13 weeks) and fiscal year (52 weeks) ended January 30, 2026 (“fiscal 2025”). · Fourth Quarter Net Sales Increased 5.9% to $10.9 Billion”

EASTMAN KODAK CO reported financial results for the fourth quarter and full year 2025.

“On March 12, 2026, Eastman Kodak Company (the "Company") issued a press release describing its fourth quarter 2025 and full year 2025 financial results. A copy of the press release is furnished as Exhibit (99.1) to this report.”

McEwen Inc. reported fourth quarter and full year 2025 results: net income $38.1M ($0.70 per Share).

“Q4 Net Income of $38.1M ($0.70 per Share) vs. Net Loss of $8.2M ($0.16 per Share) in Q4 2024”

TEAM INC reported the full year ended December 31, 2025 results: revenue $896.5 million, net income Net loss of $49.2 million.

“up 12.1% from the 2024 period. • Generated cash flow from operations of $16.8 million and Free Cash Flow 1 of $14.6 million. Full Year 2025 Highlights: • Generated revenue of $896.5 million, a 5.2% increase compared to 2024. • Grew gross margin to $231.7 million. • Reported 2025 net loss of $49.2 million, inclusive of a $13.1 million loss on debt extinguishment”

TEAM INC reported the fourth quarter ended December 31, 2025 results: revenue $224.8 million, net income Net loss of $3.8 million.

“today reported its financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Highlights: • Generated fourth quarter 2025 revenues of $224.8 million, an increase of 5.4% over the 2024 period. • Grew gross margin to $58.3 million. • Reported a net loss of $3.8 million, an improvement of $3.4 million from the 2024 period. •”

MAYS J W INC reported six months ended January 31, 2026 results: revenue Revenues from Operations for the six months ended January 31, 2026 were $10,462,896, net income Net loss from Operations for the six months ended January 31, 2026 was $(842,987), EPS $(.42) per share.

“J. W. Mays, Inc. today reported its financial results for the three and six months ended January 31, 2026. Revenues from Operations for the three months ended January 31, 2026 were $5,211,482 compared to revenues of $5,643,444 in the comparable 2025 three-month period while Revenues from Operations for the six months ended January 31, 2026 were $10,462,896 compared to revenues of $11,182,573 in the comparable 2025 six-month period. Net loss from Operations for the three months ended January 31, 2026 was $(508,960), or $(.25) per share, compared to net loss from Operations of $(157,681), or $(.08) per share, in the comparable 2025 three month period. Net loss from Operations for the six months ended January 31, 2026 was $(842,987), or $(.42) per share, compared to net loss from Operations of $(131,024), or $(.07) per share, in the comparable 2025 six month period.”

MAYS J W INC reported three and six months ended January 31, 2026 results: revenue Revenues from Operations for the three months ended January 31, 2026 were $5,211,482, net income Net loss from Operations for the three months ended January 31, 2026 was $(508,960), EPS $(.25) per share.

“J. W. Mays, Inc. today reported its financial results for the three and six months ended January 31, 2026. Revenues from Operations for the three months ended January 31, 2026 were $5,211,482 compared to revenues of $5,643,444 in the comparable 2025 three-month period while Revenues from Operations for the six months ended January 31, 2026 were $10,462,896 compared to revenues of $11,182,573 in the comparable 2025 six-month period. Net loss from Operations for the three months ended January 31, 2026 was $(508,960), or $(.25) per share, compared to net loss from Operations of $(157,681), or $(.08) per share, in the comparable 2025 three month period. Net loss from Operations for the six months ended January 31, 2026 was $(842,987), or $(.42) per share, compared to net loss from Operations of $(131,024), or $(.07) per share, in the comparable 2025 six month period.”

AMREP CORP. reported the first nine months of 2026 ended January 31, 2026 results: revenue $41,823,000, net income $9,039,000, EPS $1.68 per diluted share.

“income of $9,039,000, or $1.68 per diluted share, compared to net income of $8,823,000, or $1.64 per diluted share, for the same period of 2025. Revenues were $14,573,000 and $41,823,000 for the third quarter and first nine months of 2026 and $7,520,000 and $38,516,000 for the third quarter and first nine months of 2025. More information about the Company’s”

AMREP CORP. reported its 2026 fiscal third quarter ended January 31, 2026 results: revenue $14,573,000, net income $3,147,000, EPS $0.58 per diluted share.

“AMREP had net income of $9,039,000, or $1.68 per diluted share, compared to net income of $8,823,000, or $1.64 per diluted share, for the same period of 2025. Revenues were $14,573,000 and $41,823,000 for the third quarter and first nine months of 2026 and $7,520,000 and $38,516,000 for the third quarter and first nine months of 2025. More information about the”

KORU Medical Systems, Inc. reported full year ended December 31, 2025 results: revenue $41.1 million, net income $2.6 million or ($0.06) per diluted share, EPS ($0.06) per diluted share. Guidance initiated.

“Total net revenues increased $7.5 million, or 22.2%, to $41.1 million, for the year ended December 31, 2025, as compared with the same period last year.”

KORU Medical Systems, Inc. reported fourth quarter ended December 31, 2025 results: revenue $10.9 million, net income $0.5 million or ($0.01) per diluted share, EPS ($0.01) per diluted share.

“quarter and full year ended December 31, 2025. The Company also initiated guidance for the full year 2026. Recent Highlights ● Fourth quarter 2025 net revenues grew 23% to $10.9 million; Full year 2025 net revenues grew 22% to $41.1 million ● Full year 2025 gross profit grew 20% to $25.6 million with gross margin of 62.3% ● Full year 2025 net loss of ($2.6)”

Vaxart, Inc. reported the full year ended December 31, 2025 results: revenue $237.3 million, net income $16.3 million, EPS $0.07.

“non-dilutive funding options, with the goal of achieving its upcoming clinical and regulatory milestones and maximizing stockholder value. ● Revenue for the full year 2025 was $237.3 million, compared to $28.7 million for the full year 2024. Revenue in the full year 2025 and the full year 2024 was primarily from government contracts related to the BARDA contract”

TRANSCONTINENTAL REALTY INVESTORS INC reported the three months ended December 31, 2025 results: revenue $12.1 million, net income $8.3 million, EPS $0.97 per diluted share.

“loan on the property and for general corporate purposes. Financial Results Revenues increased $0.3 million from $11.8 million for the three months ended December 31, 2024 to $12.1 million for the three months ended December 31, 2025. The increase in revenue is primarily due to an increase of $0.6 million from our commercial properties offset in part by a decrease”

AEMETIS, INC reported three months ended December 31, 2025 results: revenue $53.7 million.

“Revenues and production tax credits were $53.7 million for the fourth quarter of 2025, an increase from $47.0 million from the fourth quarter of 2024.”

CHAMPIONS ONCOLOGY, INC. reported third quarter of fiscal 2026, ended January 31, 2026 results: revenue $16.6 million, net income $279,000. Guidance reaffirmed.

“reference in such a filing. --- EX-99.1 (EX-99.1) --- NEWS One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Reports Revenue of $16.6 Million Company remains on track to deliver year-over-year revenue growth and positive adjusted EBITDA for the fiscal year Hackensack, NJ – March 12 , 2026 – Champions Oncology, Inc.”

ADOBE INC. reported financial results for first quarter fiscal year 2026 ended February 27, 2026.

“On March 12, 2026, Adobe Inc. (“Adobe”) issued a press release announcing financial results for its first quarter fiscal year 2026 ended February 27, 2026.”

AMERICAS CARMART INC reported third quarter ended January 31, 2026 results: revenue $286.8 million, EPS $9.25.

“our ongoing operational improvement initiative Completed ACM Auto Trust 2025-4 securitization in December 2025 and issued $161.3 million in asset-backed notes Total revenue of $286.8 million, down 12.0%; interest income increased 3.1% to $64.2 million Gross profit per unit improved 8.8% to $7,762; gross margin percentage of 35.8% vs. 35.7% Total collections of $179.0”

Sleep Number Corp reported the fiscal year ended January 3, 2026 results: revenue $1.4 billion, net income $132 million. Guidance initiated.

“Net sales of $1.4 billion, down 16%, driven by driven by ongoing industry pressure and lower store traffic. • Gross profit of $833 million, a decrease of $170 million. Gross profit margin of 59.0% of net sales, down 60 bps, driven by the $9.6 million inventory write-down charge and partially offset by the benefit of product cost reductions through value engineering and ongoing supplier negotiations and ongoing efficiencies in our home delivery and logistics operations. • Operating expenses were $880 million. Adjusted operating expenses before restructuring and other non-recurring costs were $824 million, a decrease of $136 million, or 14%, driven by lower marketing and selling expenses, general and administrative expenses, and research and development expenses. • Restructuring and other non-recurring costs were $65 million, driven primarily by severance and employee-related benefits, contract termination costs due to store closures, asset impairment charges, and inventory obsolescence.”

Sleep Number Corp reported the fourth quarter ended January 3, 2026 results: revenue $347 million, net income $59 million.

“Net sales of $347 million, down 8%, driven by ongoing industry demand pressure and lower store traffic. • Gross profit of $193 million, a decrease of $32 million. Gross profit margin of 55.6% compared to 59.9% for the same period last year, primarily due to a $9.6 million inventory obsolescence charge associated with the introduction of the company's new product line. Excluding the charge, adjusted gross profit margin was 58.4%. • Operating expenses were $201 million. Adjusted operating expenses before restructuring and other non-recurring costs were $197 million, a decrease of $20 million, or 9%, driven by lower marketing and selling expenses, general and administrative expenses, and research and development expenses. • Restructuring and other non-recurring costs were $14 million, driven primarily by the $9.6 million inventory obsolescence charge and contract termination costs due to store closures. • Net loss of $59 million compared with a net loss of $5 million for the same period l”

LIFETIME BRANDS, INC reported the year ended December 31, 2025 results: revenue $647.9 million, net income $(26.9) million, EPS $(1.24) per diluted share.

“Full Year Financial Results: Consolidated net sales for the year ended December 31, 2025, were $647.9 million, a decrease of $35.1 million, or 5.1%, as compared to consolidated net sales of $683.0 million for the corresponding period in 2024. In constant currency, a non-GAAP financial measure, which excludes the impact of foreign exchange fluctuations and was determined by applying 2025 average rates to 2024 local currency amounts, consolidated net sales decreased $36.9 million, or 5.4%, as compared to consolidated net sales in the corresponding period in 2024. A table reconciling this non-GAAP financial measure to consolidated net sales, as reported, is included below. 1 Gross margin for 2025 was $240.7 million, or 37.1%, compared to $260.7 million, or 38.2%, for the corresponding period in 2024. Selling, general and administrative expenses for 2025 were $142.4 million, a decrease of $17.4 million, or 10.9%, as compared to $159.8 million for the corresponding period in 2024. Loss from”

LIFETIME BRANDS, INC reported the three months ended December 31, 2025 results: revenue $204.1 million, net income $18.2 million, EPS $0.83 per diluted share.

“Fourth Quarter Financial Results: Consolidated net sales for the three months ended December 31, 2025, were $204.1 million, representing a decrease of $11.1 million or 5.2%, as compared to $215.2 million for the corresponding period in 2024. In constant currency, a non-GAAP financial measure, which excludes the impact of foreign exchange fluctuations and was determined by applying 2025 average rates to 2024 local currency amounts, consolidated net sales decreased $12.0 million or 5.6% in the fourth quarter of 2025, as compared to consolidated net sales in the corresponding period in 2024. A table reconciling this non-GAAP financial measure to consolidated net sales, as reported, is included below. Gross margin for the three months ended December 31, 2025 was $78.8 million, or 38.6%, as compared to $81.2 million, or 37.7%, for the corresponding period in 2024. Selling, general and administrative expenses for the three months ended December 31, 2025 were $38.0 million, a decrease of $5.2”

Horizon Kinetics Holding Corp reported the year ended December 31, 2025 results: revenue $72.8 million, net income $5.1 million, EPS $0.27.

“Revenues of $72.8 million for the year ended December 31, 2025, an increase $17.0 million, or 31.0%”

SAGA COMMUNICATIONS INC reported the twelve-month period ended December 31, 2025 results: revenue $107.1 million, net income net loss of $7.9 million, EPS $1.22 per diluted share.

“Net revenue decreased 5.1% to $107.1 million for the twelve-month period ended December 31, 2025 compared to $112.9 million for the same period last year. Digital revenue increased 19.1% to $16.9 million for the twelve-month period ended December 31, 2025 compared to $14.2 million for the same period last year. Station operating expense remained flat for the twelve-month period at $91.8 million compared to the same period last year. For the twelve-month period, we had an operating loss of $11.0 million compared to operating income of $2.4 million for the same period last year and station operating income (a non-GAAP financial measure) decreased 27.3% to $15.3 million. Capital expenditures for the twelve months were $3.0 million compared to $3.8 million for the same period last year. We had a net loss of $7.9 million for the twelve-month period ended December 31, 2025, compared to net income of $3.5 million for the same period last year primarily as the result of the impairment ch”

SAGA COMMUNICATIONS INC reported the quarter ended December 31, 2025 results: revenue $26.5 million, net income net loss of $6.9 million, EPS $1.07 per diluted share.

“today reported that net revenue decreased 9.3% to $26.5 million for the quarter ended December 31, 2025 compared to $29.2 million for the same period last year. Digital revenue increased 25.8% to $4.3 million for the quarter ended December 31, 2025 compared to $3.5 million for the same period last year. Station operating expense decreased 1.9% for the quarter to $22.9 million compared to the same period last year. For the quarter, we had an operating loss of $9.5 million compared to operating income of $1.0 million for the same quarter last year and station operating income (a non-GAAP financial measure) decreased 38.7% to $3.6 million for the quarter ended December 31, 2025. Capital expenditures were $400 thousand for the quarter compared to $600 thousand for the same period last year. We had a net loss of $6.9 million for the quarter compared to net income of $1.3 million for the fourth quarter last year primarily as the result of an impairment charge disclosed below. Diluted”

Theriva Biologics, Inc. reported financial results for the full year ended December 31, 2025.

“Rockville, MD, March 12, 2026 – TherivaTM Biologics, Inc. (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today reported financial results for the full year ended December 31, 2025, and provided a corporate update.”